Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pak Med Assoc ; 73(6): 1284-1287, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-37427631

RESUMEN

This case series evaluated morbidity following rectosigmoid resection during cytoreductive surgery for advanced ovarian cancer at the Shaukat Khanum Memorial Cancer Hospital, Lahore. The data of 20 female patients with complications corresponding to the Clavien-Dindo classification was included; the patients received treatment between January 2016 and January 2021. The mean age was 45.05± 13.11 years. Complications were observed in 3 (15.0%) cases, i.e., urinary complications in 2 (66.7%), and intra-abdominal abscess in 1 (33.3%) case. Clavien-Dindo classification grade II was noted in 2 (66.7%), while grade III-B in 1 (33.3%) case. Surgical risk factors were noted as appendectomy in 6 (66.7%) cases, bowel resection in 1 (11.1%), left colectomy in 1 (11.1%), sigmoid colectomy in 1 (11.1%), and stoma formation in 11 (55.0%) cases. In this reported case series, significant complications were observed in women undergoing rectosigmoid resection as cytoreductive surgery for advanced ovarian cancer.


Asunto(s)
Neoplasias Ováricas , Proctocolectomía Restauradora , Femenino , Humanos , Adulto , Persona de Mediana Edad , Neoplasias Ováricas/cirugía , Procedimientos Quirúrgicos de Citorreducción/efectos adversos , Estudios Retrospectivos , Morbilidad , Complicaciones Posoperatorias/etiología
2.
Comput Biol Med ; 158: 106848, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37044052

RESUMEN

There has been an increasing interest in translating artificial intelligence (AI) research into clinically-validated applications to improve the performance, capacity, and efficacy of healthcare services. Despite substantial research worldwide, very few AI-based applications have successfully made it to clinics. Key barriers to the widespread adoption of clinically validated AI applications include non-standardized medical records, limited availability of curated datasets, and stringent legal/ethical requirements to preserve patients' privacy. Therefore, there is a pressing need to improvise new data-sharing methods in the age of AI that preserve patient privacy while developing AI-based healthcare applications. In the literature, significant attention has been devoted to developing privacy-preserving techniques and overcoming the issues hampering AI adoption in an actual clinical environment. To this end, this study summarizes the state-of-the-art approaches for preserving privacy in AI-based healthcare applications. Prominent privacy-preserving techniques such as Federated Learning and Hybrid Techniques are elaborated along with potential privacy attacks, security challenges, and future directions.


Asunto(s)
Inteligencia Artificial , Privacidad , Humanos , Registros Electrónicos de Salud , Atención a la Salud , Difusión de la Información
3.
Cureus ; 12(7): e9163, 2020 Jul 13.
Artículo en Inglés | MEDLINE | ID: mdl-32802600

RESUMEN

Background and objective The incidence of synchronous primary endometrial and ovarian cancer is uncommon and poses a diagnostic challenge to the treating physician about their origin as either primary or metastasis. The purpose of this study was to evaluate the clinicopathological behavior, treatment modality-related outcomes, and prognosis related to primary endometrial and ovarian cancers at a tertiary care referral center in South Asia. Methods We retrospectively analyzed 30 patients with synchronous ovarian and endometrial cancers treated at Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan from January 2005 to August 2017. Results The median age of the patients at the time of diagnosis was 51 years (range: 25-72 years). The common presenting symptoms were irregular uterine bleeding (30%), post-menopausal bleeding (26.7%), abdominal mass (16.7%), and abdominal pain (26.7%). Endometrial adenocarcinoma type was the most common histological variant found among the participants: 90% (n=27) of uterine and 56.7% (n=17) of ovarian cancers. All patients underwent surgical intervention. Among them, 25 patients received platinum-based adjuvant chemotherapy, four received neoadjuvant chemotherapy, and 18 received adjuvant radiotherapy. The early-stage group [International Federation of Gynecology and Obstetrics (FIGO) stage I and II] had a more favorable prognosis than the advanced stage group (FIGO stages III and IV). Conclusion Based on our findings, patients with synchronous primary endometrial and ovarian cancers have better overall survival rates than patients with single primary ovarian or endometrial cancers. Also, synchronous primary endometrial and ovarian cancer endometroid types have better overall survival than patients with non-endometrioid or mixed histologic types.

4.
Cureus ; 12(6): e8484, 2020 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-32642388

RESUMEN

Introduction Malignant melanoma, which arises from melanocytes or pigment cells, is one of the most common forms of epithelial cancer. Cutaneous and noncutaneous melanomas differ clinically and genetically. Mucosal melanomas are rare. In the female genital tract, the most frequent location of melanoma is the vulva, whereas the vagina is seldom affected. The occult nature of their anatomical location contributes to the late presentation and late diagnosis of vaginal melanoma, resulting in an exceedingly poor patient prognosis. The present study describes the incidence, symptoms, management, and prognosis of women in Pakistan with malignant melanoma of the vulva, vagina, and cervix. Materials and methods The Hospital Information System of Shaukat Khanam Memorial Cancer Hospital and Research Center was searched electronically to identify patients diagnosed with malignant melanoma from January 1995 to December 2017. Patients with cutaneous malignant melanoma, multiple primary tumors, and metastases to the female genital tract from primary tumors located elsewhere were excluded. All included patients had been diagnosed with primary malignant melanoma of the female genital tract. Results The search of medical records identified 271 patients with malignant melanoma, of whom 13 had primary malignant melanomas of the female genital tract. Of these 13 patients, nine, three, and one had primary vaginal, vulvar, and cervical melanomas, respectively. Median age at presentation was 60 years (range, 30-70 years), with 10 patients being post-menopausal. The most common presentations were per-vaginal bleeding and per-vaginal discharge (five patients each). The mean duration of symptoms was 7.46 months. Seven patients underwent wide local excision. Six patients had nodular type malignant melanoma, two had superficial spreading type, and five were unclassified. Nine patients had pathological T4 disease, and two had pathological T3. Mean Breslow depth was 5.4 millimeters (mm), with 10 patients having tumor depth >4 mm. Eight patients were positive for the microscopic involvement of margins. The mean time to recurrence was 11.8 months (range, 1-24 months), and the mean time to metastasis was 17.6 months (range, 2-44 months). The median survival after surgery was 25 months (range, 2-75 months). Conclusion This study is the first to report the incidence, symptoms, management, and prognosis of patients in Pakistan with malignant melanoma of the female genital tract. Meta-analyses and prospective multicenter studies are needed.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...